Return to Archive
Browse By Month
Like This?
Subscribe by email:
Cell Therapeutics, Inc. (CTIC) Has four (FDA) clinical trial updates December 31st 2012!
Sent Friday, November 30, 2012
View as html
Insiders bought over 300,000 shares today! Cell Therapeutics, Inc. (CTIC) -Nasdaq Four (FDA) updates December 31st! All on this day! Stock is a buy!!! Phase 3 Pacnitinib Phase 3 Tosedostat Phase 2 Pixantrone Phase 3 Opaxio Insiders bought 300,000 shares this morning! Short term price target is $3.25 Cell Therapeutics, Inc. 501 Elliott Avenue West Suite 400 Seattle, WA 98119 United States - Map [ http://us.rd.yahoo.com/finance/profile/map/*http://maps.yahoo.com/maps_result?addr=501%20Elliott%20Avenue%20West%20Suite%20400&csz=Seattle%20WA%2098119&country=United%20States ] Phone: 206-282-7100 Fax: 206-284-6206 Website: http://www.celltherapeutics.com [ http://www.celltherapeutics.com/ ] Cell Therapeutics, Inc. engages in the development, acquisition, and commercialization of drugs for the treatment of cancer. It is developing Pixuvri, a novel anthracycline derivative for the treatment of hematologic malignancies and solid tumors; OPAXIO, a chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate for treating ovarian, brain, esophageal, head, and neck cancers; Brostallicin, a synthetic DNA minor groove binding agent; and Bisplatinates, a platinum-based chemotherapy drug to treat various cancers. The company, in collaboration with Chroma Therapeutics, Ltd., is also engaged in developing Tosedostat, an oral aminopeptidase inhibitor. Cell Therapeutics, Inc. was founded in 1991 and is headquartered in Seattle, Washington. Stock recommendations and comments presented on HotPennyStocksOnline.com are solely those of the analysts and experts quoted. They do not represent the opinions of HotPennyStocksOnline.com on whether to buy, sell or hold shares of a particular stock. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal or corporate ownership, may influence or factor into an expert stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is no guarantee of future price appreciation [ http://www.wikinvest.com/wiki/Appreciation ]. Always do your best. What you plant now, you will harvest later. Og Mandino [ http://www.brainyquote.com/quotes/authors/o/og_mandino.html ] Kevin P. Ryan: President Sumant Chittiprolu: Vice President Matthew Fisher: CEO Anthony Lero: Director of Marketing and Sales http://hotpennystocksonline.com [ http://hotpennystocksonline.com/ ]